Orchard Takes GSK’s Rare Disease Gene Therapies

23.04.2018 - UK biotech Orchard Therapeutics has acquired GlaxoSmithKline’s (GSK) portfolio of approved and investigational rare disease gene therapies. The deal will see GSK take a 19.9%...